Related Experiment Video
Updated: May 23, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Preeclampsia (marker of chronic kidney disease): from genesis to future risks
Thais Alquezar Facca1, Gianna Mastroianni Kirsztajn, Nelson Sass
1Departamento de Obstetrícia da Escola Paulista de Medicina – EPM da Universidade Federal de São Paulo – UNIFESP, Setor de Hipertensão Arterial e Nefropatias na Gestação.
Insights
Preeclampsia (PE) is a pregnancy disorder linked to cardiovascular disease (CVD) and chronic kidney disease (CKD). A history of PE may help predict and prevent future cardiovascular and kidney risks.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Nephrology
Background:
- Preeclampsia (PE) is a pregnancy-specific hypertensive disorder affecting 3-14% of pregnancies globally.
- PE shares pathophysiological mechanisms (endothelial dysfunction, metabolic changes, oxidative stress) and risk factors (obesity, kidney disease, diabetes) with cardiovascular diseases (CVD).
Purpose of the Study:
- To explore the link between preeclampsia and the future risk of developing cardiovascular diseases (CVD) and chronic kidney disease (CKD).
- To investigate the potential of a preeclampsia history in assessing and managing future cardiovascular and kidney risks.
Main Methods:
- This study reviews existing literature on the pathophysiological links between preeclampsia and cardiovascular/kidney diseases.
- Analysis of shared risk factors and clinical presentations between PE, CVD, and CKD.
Main Results:
- Preeclampsia-induced metabolic stress can lead to vascular injury, increasing the likelihood of future CVD and/or CKD.
- The risk of developing CVD and CKD is particularly elevated in women with a history of recurrent or severe preeclampsia, including eclampsia.
Conclusions:
- A history of preeclampsia serves as a potential indicator for future cardiovascular and chronic kidney disease risk assessment.
- Early identification of women with a history of PE can aid in the prevention and early diagnosis of subsequent CVD and CKD.
Abstract:
Preeclampsia (PE) is a pregnancy-specific disease which, in addition to other hypertensive disorders, is an important cause of maternal and perinatal morbidity and mortality. With an incidence ranging from 3 to 14% of all pregnancies worldwide, the disease can present in different clinical forms. PE and cardiovascular diseases (CVD) have similar pathophysiological mechanisms, such as endothelial dysfunction, metabolic changes and oxidative stress, and they also share some risk factors such as obesity, kidney disease and diabetes. Although the exact relationship between PE and cardiovascular risk has not been fully elucidated, PE-triggered metabolic stress may cause vascular injury, thus contributing to the development of CVD and/or chronic kidney disease (CKD) in the future. This risk appears to be increased especially in women with a history of recurrent, severe PE and eclampsia. The investigation of a history of PE may assist in assessing the future risk of CVD and CKD, their prevention and early diagnosis.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Nephrotic Syndrome I : Introduction
